Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Clinical Pharmacology and Therapeutics|March 1, 1995
Regional deposition of inhaled 11C-nicotine vapor in the human airway as visualized by positron emission tomographyM Bergström, A Nordberg, E Lunell, et al.
European Journal of Clinical Pharmacology|January 1, 1982
Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung diseaseE Lunell, N Svedmyr, K E Andersson, et al.
European Journal of Respiratory Diseases|July 1, 1983
A novel bronchodilator xanthine apparently without adenosine receptor antagonism and tremorogenic effectE Lunell, N Svedmyr, K E Andersson, et al.
Clinical Pharmacokinetics|October 19, 2001
The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatmentsN G Schneider, R E Olmstead, M A Franzon, et al.
Clinical Pharmacokinetics|July 1, 1996
Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systemsN G Schneider, E Lunell, R E Olmstead, et al.
Clinical Pharmacology and Therapeutics|October 3, 2000
Pharmacokinetics of nicotine in kidney failureL Molander, A Hansson, E Lunell, et al.
Pharmacology & Toxicology|October 1, 1988
No effect of roxithromycin on pharmacokinetic or pharmacodynamic properties of warfarin and its enantiomersO Paulsen, L G Nilsson, B Saint-Salvi, et al.
Toxicology and Applied Pharmacology|March 4, 2000
Acute effects of nicotine infusion on platelets in nicotine users with normal and impaired renal functionP A Whiss, T H Lundahl, T Bengtsson, et al.
Clinical Pharmacology and Therapeutics|December 1, 1983
Enprofylline kinetics in healthy subjects after single dosesO Borgå, K E Andersson, L E Edholm, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Absorption of enprofylline from the gastrointestinal tract in healthy subjectsE Lunell, K E Andersson, O Borgå, et al.
Pageof 3